ALMU Nasdaq Semiconductors & Related Devices Financials FY2021βFY2026
Aeluma, Inc. had $4.5M of revenue in fiscal 2026, down 4.4% on the year before. Over five years, revenue changed +436.9% a year on average.
Last close Β· Oct 23, 2026
$6.91
3.6%Hi! I read Aeluma, Inc.βs latest annual report (fiscal 2026). Here is what stands out:
Good So-so Weak
Are sales growing?
β4.4%
No. Sales fell 4.4% last year.
Does it make a profit?
β205.3%
No. It lost money last year.
Does profit turn into cash?
β87.7%
No. It spent more cash than it brought in.
How healthy are the accounts?
3 / 8
Weak. It passes 3 of 8 health tests.
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
KIRA Β· Aeluma, Inc. had $4.5M of revenue in fiscal 2026, down 4.4% on the year before. Over five years, revenue changed +436.9% a year on average. Its operating margin was β228.3%, down 182.4Β pts: of every 100 in sales, about β228 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
KIRA Β· Aeluma, Inc. lost $9.2M in fiscal 2026.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Net income
Diluted EPS
Diluted EPS
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was β$3.9M in fiscal 2026, β87.7% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· In the last 12 months, insiders sold $15.3M of shares on the open market and bought none.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$15.3M
3 insiders
Of sales under plans
41%
$6.2M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 12, 2026 | Jonathan KlamkinChief Executive Officer, Director | Sold plan | 100,000 | $10.53 | $1.1M | Form 4 |
| Sep 21, 2026 | Jonathan KlamkinChief Executive Officer, Director | Sold plan | 100,000 | $13.35 | $1.3M | Form 4 |
| Aug 27, 2026 | Steven DenbaarsDirector | Sold | 12,500 | $13.82 | $0.2M | Form 4 |
| Aug 26, 2026 | Steven DenbaarsDirector | Sold | 12,500 | $13.84 | $0.2M | Form 4 |
| Aug 3, 2026 | Jonathan KlamkinChief Executive Officer, Director | Sold plan | 20,000 | $16.73 | $0.3M | Form 4 |
| Jul 1, 2026 | Jonathan KlamkinChief Executive Officer, Director | Sold plan | 20,000 | $21.08 | $0.4M | Form 4 |
| Jun 1, 2026 | Jonathan KlamkinChief Executive Officer, Director | Sold plan | 20,000 | $25.04 | $0.5M | Form 4 |
| May 20, 2026 | Steven DenbaarsDirector | Sold plan | 12,500 | $20.47 | $0.3M | Form 4 |
| May 19, 2026 | Steven DenbaarsDirector | Sold plan | 12,500 | $19.99 | $0.2M | Form 4 |
| May 1, 2026 | Jonathan KlamkinChief Executive Officer, Director | Sold plan | 20,000 | $24.96 | $0.5M | Form 4 |
| Apr 1, 2026 | Jonathan KlamkinChief Executive Officer, Director | Sold plan | 20,000 | $13.10 | $0.3M | Form 4 |
| Mar 4, 2026 | Jonathan KlamkinChief Executive Officer, Director, 10% owner | Sold plan | 50,000 | $18.05 | $0.9M | Form 4 |
| Feb 26, 2026 | Steven DenbaarsDirector | Sold plan | 12,500 | $15.85 | $0.2M | Form 4 |
| Feb 25, 2026 | Steven DenbaarsDirector | Sold plan | 12,500 | $17.58 | $0.2M | Form 4 |
| Feb 4, 2026 | Mark N. TompkinsFormer 10% Owner | Sold | 34,500 | $14.71 | $0.5M | Form 4 |
| Feb 2, 2026 | Mark N. Tompkins10% owner | Sold | 37,500 | $15.74 | $0.6M | Form 4 |
| Jan 30, 2026 | Mark N. Tompkins10% owner | Sold | 25,000 | $15.91 | $0.4M | Form 4 |
| Jan 29, 2026 | Mark N. Tompkins10% owner | Sold | 32,500 | $16.82 | $0.5M | Form 4 |
| Jan 22, 2026 | Mark N. Tompkins10% owner | Sold | 30,000 | $18.07 | $0.5M | Form 4 |
| Jan 21, 2026 | Mark N. Tompkins10% owner | Sold | 45,000 | $18.82 | $0.8M | Form 4 |
| Jan 20, 2026 | Mark N. Tompkins10% owner | Sold | 30,000 | $20.69 | $0.6M | Form 4 |
| Dec 26, 2025 | Mark N. Tompkins10% owner | Sold | 30,000 | $17.79 | $0.5M | Form 4 |
| Dec 24, 2025 | Mark N. Tompkins10% owner | Sold | 15,000 | $16.05 | $0.2M | Form 4 |
| Dec 23, 2025 | Mark N. Tompkins10% owner | Sold | 15,000 | $14.87 | $0.2M | Form 4 |
| Dec 22, 2025 | Mark N. Tompkins10% owner | Sold | 35,000 | $14.83 | $0.5M | Form 4 |
| Dec 19, 2025 | Mark N. Tompkins10% owner | Sold | 30,000 | $14.70 | $0.4M | Form 4 |
| Dec 18, 2025 | Mark N. Tompkins10% owner | Sold | 20,000 | $14.37 | $0.3M | Form 4 |
| Dec 10, 2025 | Mark N. Tompkins10% owner | Sold | 20,000 | $17.49 | $0.3M | Form 4 |
| Dec 9, 2025 | Mark N. Tompkins10% owner | Sold | 30,000 | $16.82 | $0.5M | Form 4 |
| Dec 8, 2025 | Mark N. Tompkins10% owner | Sold | 40,000 | $16.06 | $0.6M | Form 4 |
| Dec 5, 2025 | Mark N. Tompkins10% owner | Sold | 30,000 | $16.14 | $0.5M | Form 4 |
| Dec 4, 2025 | Mark N. Tompkins10% owner | Sold | 30,000 | $16.03 | $0.5M | Form 4 |
| Oct 20, 2025 | Mark N. Tompkins10% owner | Sold | 37,500 | $16.39 | $0.6M | Form 4 |
| Oct 17, 2025 | Mark N. Tompkins10% owner | Sold | 40,000 | $16.93 | $0.7M | Form 4 |
| Oct 16, 2025 | Mark N. Tompkins10% owner | Sold | 25,000 | $19.29 | $0.5M | Form 4 |
| Oct 15, 2025 | Mark N. Tompkins10% owner | Sold | 40,000 | $20.59 | $0.8M | Form 4 |
| Oct 14, 2025 | Mark N. Tompkins10% owner | Sold | 36,855 | $19.86 | $0.7M | Form 4 |
| Oct 13, 2025 | Mark N. Tompkins10% owner | Sold | 35,331 | $16.98 | $0.6M | Form 4 |
| Oct 10, 2025 | Mark N. Tompkins10% owner | Sold | 35,000 | $16.67 | $0.6M | Form 4 |
| Oct 9, 2025 | Mark N. Tompkins10% owner | Sold | 36,908 | $16.56 | $0.6M | Form 4 |
| Oct 8, 2025 | Mark N. Tompkins10% owner | Sold | 35,000 | $17.47 | $0.6M | Form 4 |
| Oct 7, 2025 | Mark N. Tompkins10% owner | Sold | 35,000 | $17.75 | $0.6M | Form 4 |
| Oct 6, 2025 | Mark N. Tompkins10% owner | Sold | 63,604 | $18.70 | $1.2M | Form 4 |
| Oct 3, 2025 | Mark N. Tompkins10% owner | Sold | 31,147 | $17.57 | $0.5M | Form 4 |
| Oct 2, 2025 | Mark N. Tompkins10% owner | Sold | 35,000 | $17.10 | $0.6M | Form 4 |
| Oct 1, 2025 | Mark N. Tompkins10% owner | Sold | 50,500 | $16.87 | $0.9M | Form 4 |
| Sep 30, 2025 | Mark N. Tompkins10% owner | Sold | 33,580 | $16.19 | $0.5M | Form 4 |
| Sep 29, 2025 | Mark N. Tompkins10% owner | Sold | 25,000 | $17.57 | $0.4M | Form 4 |
Can it carry its debts, and how well does it use its money?
Cash, debt and the ratios that show how comfortably Aeluma, Inc. can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $3.7M | $5.1M | $1.3M | $3.6M | $56.0M |
| Debt incl. finance leases | $0.9M | $0.6M | β | β | β |
| Debt / equity | 0.1x | 0.0x | β | β | β |
| Current ratio | 11.9x | 7.0x | 2.2x | 24.6x | 30.3x |
| Quick ratio | 11.9x | 7.0x | 2.2x | 24.6x | 30.3x |
| Total assets | $5.9M | $7.2M | $3.8M | $19.4M | $60.7M |
| Total liabilities | $0.8M | $1.1M | $1.6M | $1.5M | $3.7M |
| Shareholders' equity | $5.1M | $6.1M | $2.3M | $17.9M | $56.9M |
| Net debt (β = net cash) | β$2.8M | β$4.5M | β | β | β |
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
KIRA Β· Aeluma, Inc. passes 3 of 8 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β |
| F-score | β / 3 | β / 1 | β / 5 | 2 / 8 | 5 / 8 | 3 / 8 |
| Accruals ratio | β7.8% | β | β26.6% | β20.1% | β16.1% | β14.7% |
| Altman Z'' | β | β | 0.99 | β16.70 | 14.55 | 19.50 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $0.0M | β | $0.2M | $0.9M | $4.7M | $4.5M |
| Net interest income | $0.0M | β | β | β | β | β |
| Gross profit | β | β | $0.1M | $0.3M | $2.8M | $1.6M |
| Research and development | β | β | $2.5M | $2.5M | $1.3M | $4.7M |
| Operating income | β | β | β$5.5M | β$4.6M | β$2.1M | β$10.2M |
| Pretax income | β$0.0M | β | β$5.4M | β$4.6M | β$3.0M | β$9.2M |
| Income tax | $0.0M | β | β | β | β | β |
| Net income | β$0.0M | β | β$5.4M | β$4.6M | β$3.0M | β$9.2M |
| Diluted EPS | β$0.02 | β | β$0.47 | β$0.37 | β$0.23 | β$0.52 |
| Diluted shares | 0.00B | β | 0.01B | 0.01B | 0.01B | 0.02B |
| Cash flow | ||||||
| Cash from operations | β$0.0M | β | β$3.6M | β$3.5M | β$1.1M | β$3.3M |
| Capital expenditure | $0.1M | β | $0.6M | $0.3M | $0.2M | $0.6M |
| Free cash flow | β$0.1M | β | β$4.2M | β$3.8M | β$1.3M | β$3.9M |
| Depreciation and amortization | β | β | $0.2M | $0.3M | $0.4M | $0.5M |
| Stock-based compensation | β | β | $0.4M | $0.7M | $1.9M | $4.5M |
| Share buybacks | β | β | β | $0.0M | β | β |
| Dividends and buybacks | β | β | β | $0.0M | β | β |
| Balance sheet | ||||||
| Cash and short-term investments | $0.0M | $3.7M | $5.1M | $1.3M | $3.6M | $56.0M |
| Total debt | β | $0.5M | $0.3M | β | β | β |
| Finance lease liabilities | β | $0.5M | $0.3M | β | β | β |
| Current assets | $0.0M | $4.4M | $5.3M | $1.4M | $17.3M | $57.3M |
| Current liabilities | $0.1M | $0.4M | $0.8M | $0.6M | $0.7M | $1.9M |
| Property and equipment, net | β | $1.0M | $1.5M | $1.5M | $1.2M | $1.4M |
| Intangible assets | β | $0.0M | $0.0M | $0.0M | $0.0M | β |
| Total assets | $0.2M | $5.9M | $7.2M | $3.8M | $19.4M | $60.7M |
| Total liabilities | $0.1M | $0.8M | $1.1M | $1.6M | $1.5M | $3.7M |
| Shareholders' equity | $0.0M | $5.1M | $6.1M | $2.3M | $17.9M | $56.9M |
| Margins | ||||||
| Gross margin | β | β | 43.4% | 32.6% | 59.6% | 35.2% |
| Operating margin | β | β | β2,850.3% | β496.5% | β45.9% | β228.3% |
| EBITDA margin | β | β | β2,743.5% | β462.7% | β37.0% | β218.2% |
| Net margin | β1,350.0% | β | β2,783.0% | β496.4% | β64.8% | β205.3% |
| FCF margin | β10,760.0% | β | β2,187.3% | β411.0% | β28.1% | β87.7% |
| Net interest share of revenue | 100.0% | β | β | β | β | β |
| Returns | ||||||
| Return on capital | β | β | β326.1% | β | β | β |
| Return on capital employed | β | β | β86.0% | β141.8% | β11.5% | β17.3% |
| Return on equity | β214.3% | β | β96.0% | β108.8% | β30.0% | β24.5% |
| Return on assets | β8.8% | β | β82.2% | β82.9% | β26.0% | β22.9% |
| Return on tangible equity | β214.3% | β | β88.2% | β201.1% | β16.9% | β16.1% |
| Growth | ||||||
| Revenue growth | β | β | β | 375.4% | 407.6% | β4.4% |
| Share count change | β | β | β | 8.1% | 7.1% | 34.2% |
| Financial health | ||||||
| Debt / equity | β | 0.1x | 0.0x | β | β | β |
| Current ratio | 0.3x | 11.9x | 7.0x | 2.2x | 24.6x | 30.3x |
| Quick ratio | 0.3x | 11.9x | 7.0x | 2.2x | 24.6x | 30.3x |
| Capital allocation | ||||||
| Capex / revenue | 10,620.0% | β | 305.2% | 35.0% | 3.5% | 14.5% |
| Stock comp / revenue | β | β | 232.0% | 79.7% | 40.6% | 101.3% |
| Quality scores | ||||||
| Piotroski F-score | β | β | β | 2.0 | 5.0 | 3.0 |
| Altman Z'' | β | β | 1.0 | β16.7 | 14.5 | 19.5 |
| Accruals ratio | β7.8% | β | β26.6% | β20.1% | β16.1% | β14.7% |
Source: SEC EDGAR XBRL filings (CIK 0001828805). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
